Form 4: EHC Director Carmichael Receives 23 RSUs

Encompass Health Director Greg D. Carmichael received 23 restricted stock units on October 15, 2025, as part of a routine dividend payment plan.

Summary

• Greg D. Carmichael, a Director of Encompass Health Corp (EHC), acquired 23 non-derivative securities.
• The transaction occurred on October 15, 2025.
• These securities are Restricted Stock Units (RSUs) awarded in connection with common stock dividend payments.
• The number of RSUs credited is calculated based on the number of RSUs in the director's account, the per share dividend, and the closing price on the dividend payment date.
• Encompass Health paid a dividend of $0.19 per share on October 15, 2025, with a closing price of $123.65.
• Following this transaction, Greg D. Carmichael beneficially owns 18,631 shares directly.

Sentiment

Score: 6

Explanation: The sentiment is mildly positive. While a routine transaction, it signifies continued director alignment with shareholder interests through increased equity ownership, albeit not through a direct cash purchase.

Positives

• The acquisition of additional Restricted Stock Units by a director increases their beneficial ownership, further aligning their interests with those of shareholders.
• The RSU award mechanism tied to dividend payments demonstrates a structured and transparent compensation policy for non-employee directors.

Negatives

• The transaction represents an award of RSUs rather than an open market purchase, which typically signals less direct conviction in the company's immediate stock performance compared to a cash buy.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This transaction is a routine insider filing common in publicly traded companies, reflecting a standard component of non-employee director compensation plans, where equity awards are granted or adjusted based on company performance or dividend distributions. Such practices are prevalent across the healthcare services industry to align director incentives with long-term shareholder value.

Comparison to Industry Standards

• The practice of awarding Restricted Stock Units (RSUs) to non-employee directors, often tied to dividend payments, is a common compensation structure across various industries, including healthcare. This method helps align director interests with long-term shareholder value without requiring immediate cash outlay from the director.
• The specific calculation method, linking RSU credits to dividend payments and stock price, is a standard approach for dividend equivalent rights (DERs) on unvested equity awards, ensuring that RSU holders receive the economic benefit of dividends.

Stakeholder Impact

• Shareholders: The increase in director equity ownership, even through an RSU award, generally signals a stronger alignment of management and director interests with long-term shareholder value.

Key Dates

Recommendation

This Form 4 filing details a routine, non-cash acquisition of a small number of Restricted Stock Units by a director as part of a pre-existing compensation plan tied to dividend payments. It does not represent a significant change in the director's overall beneficial ownership or a discretionary purchase signaling new conviction. Therefore, this specific filing alone is not sufficient to alter an investment recommendation, and a 'hold' stance is maintained based on broader company fundamentals rather than this isolated event.

Keywords

Encompass Health, EHC, Insider Transaction, Form 4, Restricted Stock Units, Director Compensation, Dividend Reinvestment, Corporate Governance